Schizophrenia News

Boehringer Ingelheim and Click Therapeutics have announced the launch of an expanded collaboration for development and commercialization of a second prescription digital therapeutic for those diagnosed with schizophrenia.

A nutritional program that focused on increased intake of prebiotics and probiotics improved cardiometabolic health in patients with schizophrenia spectrum disorders, according to a study published in BMC Psychiatry.

For adults in Denmark, diagnosis of mental disorders led to a significant impact on the number of working years when compared with the general population, according to a study published in Lancet Psychiatry.

A multidiagnostic prediction model developed using deep learning was highly predictive of mental disorder diagnosis, according to new data published in JAMA Psychiatry.

For adults in the U.K., preexisting neuropsychiatric conditions and having a prescription for a related treatment carried a significantly increased risk of severe outcomes from COVID-19 and other severe acute respiratory infections.

Digital health solutions company Twill has announced a partnership with e-Psychiatry, a telepsychiatry and teletherapy service, that it says will provide increased human and digital mental health support for patients.

Teva Pharmaceuticals announced it recently completed resubmission of a new drug application to the FDA for mdc-IRM, a risperidone subcutaneous long-acting injectable for the treatment of schizophrenia.

Risk for developing mental illness among North Korean refugees and immigrants living in South Korea was significantly higher than for those in the general population, according to a study published in JAMA Network Open.

In a cohort of United States military veterans, relapse of schizophrenia symptoms was associated with higher rates of adverse socioeconomic outcomes, according to a study published in the Journal of Clinical Psychiatry.

HHS has released its “Roadmap for Behavioral Health Integration,” which details policy solutions to help integrate mental health and substance use care into large health care systems.